Joy Yan - 01 Mar 2022 Form 4 Insider Report for Moleculin Biotech, Inc. (MBRX)

Role
Director
Signature
/s/ Jonathan Foster by Power of Attorney
Issuer symbol
MBRX
Transactions as of
01 Mar 2022
Transactions value $
$0
Form type
4
Filing time
02 Mar 2022, 20:48:20 UTC
Previous filing
17 Dec 2021
Next filing
31 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MBRX Stock Option (right to buy) Award +6,667 6,667 01 Mar 2022 Common Stock 6,667 $1.38 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options set forth in this table vest in three equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service on the Company's Board of Directors on each vesting date.
F2 The options were issued in connection with the reporting person's Board of Director service to the Company.